C1(S([N:10]2[CH2:14][CH:13]([C:15]3[CH:16]=[C:17]([C:21]4[CH:26]=[CH:25][CH:24]=[C:23]([S:27]([CH3:30])(=[O:29])=[O:28])[CH:22]=4)[CH:18]=[CH:19][CH:20]=3)[N:12]([CH:31]([CH3:33])[CH3:32])[C:11]2=[O:34])(=O)=O)C=CC=CC=1.[Mg]>CO>[CH:31]([N:12]1[CH:13]([C:15]2[CH:16]=[C:17]([C:21]3[CH:26]=[CH:25][CH:24]=[C:23]([S:27]([CH3:30])(=[O:28])=[O:29])[CH:22]=3)[CH:18]=[CH:19][CH:20]=2)[CH2:14][NH:10][C:11]1=[O:34])([CH3:33])[CH3:32]1-Benzenesulfonyl-3-isopropyl-4-(3′-methanesulfonyl-biphenyl-3-yl)-imidazolidin-2-one (example 12, step 2, 1.386 g) and magnesium (0.541 g) were suspended in methanol (30 mL). The mixture was heated to reflux for 4 h and subsequently filtered. The filtrate was concentrated and the product was purified by column chromatography (SiO2, cyclohexane/ethyl acetate 7:3=>0:1) to give 1-isopropyl-5-(3′-methanesulfonyl-biphenyl-3-yl)-imidazolidin-2-one (0.293 g) as a colorless solid. MS: 359.1 ([M+H]+)